7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Evolving Applications of Artificial Intelligence and Machine Learning in Infectious Diseases Testing

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Artificial intelligence (AI) and machine learning (ML) are poised to transform infectious disease testing. Uniquely, infectious disease testing is technologically diverse spaces in laboratory medicine, where multiple platforms and approaches may be required to support clinical decision-making. Despite advances in laboratory informatics, the vast array of infectious disease data is constrained by human analytical limitations. Machine learning can exploit multiple data streams, including but not limited to laboratory information and overcome human limitations to provide physicians with predictive and actionable results. As a quickly evolving area of computer science, laboratory professionals should become aware of AI/ML applications for infectious disease testing as more platforms are become commercially available.

          Content

          In this review we: ( a) define both AI/ML, ( b) provide an overview of common ML approaches used in laboratory medicine, ( c) describe the current AI/ML landscape as it relates infectious disease testing, and ( d) discuss the future evolution AI/ML for infectious disease testing in both laboratory and point-of-care applications.

          Summary

          The review provides an important educational overview of AI/ML technique in the context of infectious disease testing. This includes supervised ML approaches, which are frequently used in laboratory medicine applications including infectious diseases, such as COVID-19, sepsis, hepatitis, malaria, meningitis, Lyme disease, and tuberculosis. We also apply the concept of “data fusion” describing the future of laboratory testing where multiple data streams are integrated by AI/ML to provide actionable clinical knowledge.

          Related collections

          Most cited references65

          • Record: found
          • Abstract: found
          • Article: found

          The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

          Definitions of sepsis and septic shock were last revised in 2001. Considerable advances have since been made into the pathobiology (changes in organ function, morphology, cell biology, biochemistry, immunology, and circulation), management, and epidemiology of sepsis, suggesting the need for reexamination.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

            Key Points Question What proportion of coronavirus disease 2019 (COVID-19) spread is associated with transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from persons with no symptoms? Findings In this decision analytical model assessing multiple scenarios for the infectious period and the proportion of transmission from individuals who never have COVID-19 symptoms, transmission from asymptomatic individuals was estimated to account for more than half of all transmission. Meaning The findings of this study suggest that the identification and isolation of persons with symptomatic COVID-19 alone will not control the ongoing spread of SARS-CoV-2.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

              An American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference was held in Northbrook in August 1991 with the goal of agreeing on a set of definitions that could be applied to patients with sepsis and its sequelae. New definitions were offered for some terms, while others were discarded. Broad definitions of sepsis and the systemic inflammatory response syndrome were proposed, along with detailed physiologic parameters by which a patient may be categorized. Definitions for severe sepsis, septic shock, hypotension, and multiple organ dysfunction syndrome were also offered. The use of severity scoring methods when dealing with septic patients was recommended as an adjunctive tool to assess mortality. Appropriate methods and applications for the use and testing of new therapies were recommended. The use of these terms and techniques should assist clinicians and researchers who deal with sepsis and its sequelae.
                Bookmark

                Author and article information

                Journal
                Clin Chem
                Clin Chem
                clinchem
                Clinical Chemistry
                Oxford University Press
                0009-9147
                1530-8561
                January 2022
                30 December 2021
                30 December 2021
                : 68
                : 1
                : 125-133
                Affiliations
                [1 ] Department of Pathology and Laboratory Medicine, UC Davis School of Medicine , CA
                [2 ] Department of Emergency Medicine, UC Davis School of Medicine , CA
                [3 ] Department of Internal Medicine, Division of Infectious Diseases, UC Davis School of Medicine , CA
                Author notes
                Address correspondence to: N.K.T. at Department of Pathology and Laboratory Medicine, University of California Davis, 4400 V St. Sacramento, CA 95817, USA. E-mail nktran@ 123456ucdavis.edu . H.H.R. at Department of Pathology and Laboratory Medicine, University of California Davis, 4400 V St., Sacramento, CA 95817, USA. Fax 916-734-0431; e-mail hrashidi@ 123456ucdavis.edu .
                Article
                hvab239
                10.1093/clinchem/hvab239
                9383167
                34969102
                91ffdcbe-4d91-43ef-8ab3-0a74e06b56cc
                © American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com.

                This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

                This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                : 01 June 2021
                : 15 October 2021
                Page count
                Pages: 9
                Categories
                Reviews
                AcademicSubjects/MED00530
                AcademicSubjects/MED00690
                AcademicSubjects/SCI00980
                AcademicSubjects/SCI01290

                covid-19,data stream,electronic medical records,immunoassays,lyme disease,meningitis,point-of-care testing,predictive analytics,sensor fusion,sepsis,tuberculosis

                Comments

                Comment on this article